Retina

Volume and area changes in retinal pigment epithelial detachments (PEDs) could indicate the need for retreatment in eyes undergoing SD-OCT guided anti-VEGF therapy.

Monthly intravitreal aflibercept significantly improves visual acuity (VA) in patients with macular oedema secondary to central retinal vein occlusion (CRVO), according to the latest phase of the COPERNICUS study.

Bevacizumab could play a role in treating Coats' disease, claims a recent study.

Indocyanine green (ICG) enhanced transpupillary thermotherapy (TTT) in combination with ophthalmic artery chemosurgery can effectively treat retinoblastoma refractory without ocular side effects, claims a study.

Anti-VEGF therapy doesn?t not significantly affect visual acuity and metamorphopsia in patients treated for retinal pigment epithelium tears in eyes, according to a paper featured in Retina.

Optos is urging skiers to ensure they take care of their eyesight while on the slopes this winter, according to their latest press release.

Ozurdex could have a beneficial effect on the visual prognosis in branch retinal vein occlusion (BRVO), reveals a study in Eye.

Adalimumab is an effective treatment for patients with active non-infectious uveitis, according to a recent investigation.

Microperimetry may provide additional information on macula function that is not available using visual acuity data.

Silicone oil removal time could be increased for up to one year to achieve a stable retinal status in patients with high-risk redetachment.

Using a gas tamponade, compared to an air tamponade, is more effective when treating rhegmatogenous retinal detachment (RRD).

An AMD campaign has been launched by the AMD Alliance International (AMDAI), World Blind Union (WBU) and the International Agency for the Prevention of Blindness (IAPB).

Treatment of blepharitis before injection, avoidance of subconjunctival anaesthesia and topical antibiotic administration immediately after injection all contribute to minimizing the risk of contracting post-intravitreal anti-VEGF endophthalmitis (PIAE).

Iluvien is not recommended for the treatment of DME in the UK, announced the National Institute for Health and Clinical Excellence (NICE).

Chronic macula holes (MHs) have distinct features compared to those of acute symptomatic MH on OCT findings.

The Royal National Institute of the Blind (RNIB) require 300 patients and carers to participate in two research projects.

Retained viscoelastic at the graft-host interface during DSEK may cause a reticular interface haze that can compromise visual clarity.

Indocyanine green angiography (ICGA) correlate with OCT findings of polypoidal lesions in polypoidal choroidal vasculopathy.

Ranibizumab injections could cause geographic atrophy (GA) progression in eyes with choroidal neovascularisation (CNV).

Intravitreal anti-VEGF monotherapy is safe and effective in treatment-naïve subretinal neovascular membrane (SRNVM) secondary to macular telangiectasia (Mactel).

Phacoemulsification is linked to a higher rate of posterior capsule rupture in vitrectomized eyes, compared to combined vitrectomy and cataract surgery.

Prophylactic treatment of retinal breaks during vitrectomy appears to reduce the risk of postoperative retinal detachment (RD).

The National Institute for Health and Clinical Excellence (NICE) recommends the use of ranibizumab for patients with diabetic macular oedema (DME).

Decreased choroidal thickness could increase vascular endothelial growth factor (VEGF) and cause tissue hypoxia.

Fundus autofluorescence (FAF) imaging could be a useful tool for assessing patients with serpiginous choroidopathy (SC) and serpiginous-like choroidopathy (SLC).

The photoreceptor inner segment/outer segment (IS/OS) junction integrity can be affected by drusen evolution.

The Rapid Assessment of Avoidable Blindness (RAAB) framework can be used to assess diabetes and diabetic retinopathy (DR) but us costly and time consuming.

A ranibizumab and photodynamic therapy combination can improve visual acuity and reduce exudation in polypoidal choroidal vasculopathy.

Invitreal injection of ocriplasmin resolves vitremacular traction and closes macular holes.

Anti-VEGF therapy pegaptanib is efficacious and non-toxic for patients with retinopathy of prematurity (ROP), states a recent study.